The breach-of-contract retrial on liability creates binary risk for Sandoz — a loss would eliminate the $61.6M award entirely. Watch for trial scheduling and any settlement discussions between Sandoz and United Therapeutics. The affirmed antitrust dismissal removes a major overhang for UTC, but the revived tortious interference claim adds a new, narrower risk.
Price Chart
Executive Summary
The Third Circuit reversed the grant of summary judgment in favor of Sandoz on its breach-of-contract claim against United Therapeutics, finding the settlement agreement ambiguous, and remanded for trial on liability. The court also reversed summary judgment for UTC on the tortious interference claim, remanding for independent analysis, but affirmed dismissal of Sandoz's antitrust claims, finding UTC had procompetitive justifications for its cartridge restrictions. The $61.6M damages award was vacated pending the breach-of-contract retrial.
Court Ruling Details
Key Facts
- Third Circuit reversed summary judgment on breach-of-contract liability, finding the settlement agreement ambiguous and remanding for trial.
- Third Circuit affirmed dismissal of Sherman Act antitrust claims, ruling UTC's cartridge restrictions had procompetitive justifications.
- Third Circuit reversed dismissal of tortious interference claim, remanding for independent analysis from antitrust claims.
- District Court's $61,643,251 damages award to Sandoz on the breach-of-contract claim was vacated pending retrial.
- Third Circuit affirmed denial of UTC's Daubert motion to exclude Sandoz's damages expert Dr. Anupam Jena.
Financial Impact
$61.6M damages award vacated; breach-of-contract claim remanded for trial on liability; antitrust claims dismissed with no damages
Risk Factors
- Sandoz may lose at trial on breach-of-contract liability, eliminating the $61.6M damages award
- Tortious interference claim could result in damages if UTC's conduct is found malicious or dishonest
- Appeal of Daubert ruling or other evidentiary issues could further delay resolution
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-c4130960f2-SDZ |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | Court Ruling | — | awaiting T+20 | — | — |
Oct 7, 2026 19d ago | Court Ruling | — | awaiting T+20 | — | — |
Sep 30, 2026 26d ago | Court Ruling | — | awaiting T+20 | — | — |
Sep 30, 2026 26d ago | Court Ruling | — | awaiting T+20 | — | — |
Sep 11, 2026 6w ago | Court Ruling | — | awaiting T+20 | — | — |
Aug 12, 2026 10w ago | Court Ruling | — | awaiting T+20 | — | — |
Aug 6, 2026 11w ago | Court Ruling | — | awaiting T+20 | — | — |
Jul 22, 2026 13w ago | Court Ruling | — | awaiting T+20 | — | — |
Jul 8, 2026 15w ago | Court Ruling | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers